Health IT

Antarctic research scientists raise $600K for gene discovery software firm

Evozym Biologics, founded in 2009 by Antarctic research scientists at the University of Delaware and the Desert Research Institute, has raised $600,000 to fund business development and strategic partnerships for its gene discovery software and database business. Funding for the Lewes, Delaware company came from core investors, said Joseph Grzymski, the president and co-founder of […]

Evozym Biologics, founded in 2009 by Antarctic research scientists at the University of Delaware and the Desert Research Institute, has raised $600,000 to fund business development and strategic partnerships for its gene discovery software and database business.

Funding for the Lewes, Delaware company came from core investors, said Joseph Grzymski, the president and co-founder of Evozym.

Its proprietary algorithms and databases focus on the diversity of natural solutions to environmental challenges that impact genomes of living organisms and have applications for the energy and biopharmaceutical sectors, among others.

It aims to accelerate the discovery of useful proteins for biofuels production and drug development, saving industries significant time and R&D costs.

In June, it began a strategic collaboration with Genscript USA — the single-largest synthesizer of DNA — to use Envozym’s software.

Adam Marsh is a co-founder of the company and a professor of marine bioscience at the University of Delaware’s College of Earth Ocean and Environment, and Grzymski is a microbiologist at the Desert Research Institute who integrates laboratory and field research at the molecular and biophysical level with computational biology.

Grzymski told MedCity News that the idea for the company came about by accident when they collaborated on an Antarctic research project in which they set out to examine how organisms adapt to extreme environments.